CML Vaccine - Chronic Myeloid Leukemia
Wilm’s Tumor Vaccine Effective for CML
February 5, 2013, Medical Automation
Winning the Battle Against Leukemia: Positive Early Results in Clinical Trial for DNA Vaccine
December 7, 2012, Science Daily
Inovio
Pharmaceuticals Announces Positive Interim Results in Phase II Leukemia Trial
December 6, 2012, The Sacramento Bee
Vaccine researchers find a possible new approach to overcoming leukemia
September 26, 2011, City of Hope
Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice
August 25, 2011, Journal Blood
Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
June 29, 2011, PrNewswire
Southampton Scientists Develop New Cancer Vaccine
March 2011, Express Healthcare
Inovio Starts Phase II Study for Leukemia DNA Vaccine
February 2, 2011, Pharmapolis
Patient Trials of New Leukemia Cancer Vaccine Begun
January 31, 2011, Science Daily
Southampton scientists begin patient trials of new leukemia cancer vaccine
January 31, 2011, Physorg.com
WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient.
October 2010, CMLHope.Com
BioSante Announces FDA Orphan Drug Designation For GVAX Chronic Myeloid Leukemia Cancer Vaccine
June 2010, Medical News Today
WT1 PEPTIDE VACCINATION IN COMBINATION WITH IMATINIB THERAPY FOR A PATIENT WITH CML IN THE CHRONIC PHASE
April 2010, International Journal of Medical Sciences
BioSante Announces Positive Leukemia Vaccine Results
March 2010, BioSante Pharmaceuticals
Vaccine may cure chronic myeloid leukemia CML
January 10, 2010, Health Newstrack
Preliminary studies show cancer vaccine may reduce tumor cells in CML patients
January 2010, The Medical news
K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate
January 1, 2010, PublMed
Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
March 2006, clinicaltrials.gov
Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome
December 2005, clinicaltrials.gov
TRIALS
WT1 immunity via DNA vaccination in haematological malignancies by intramuscular injection and electroporation
A study looking at a new vaccine to treat leukaemia (WIN)
WT1 Immunity via DNA fusion Gene Vaccination in Haematological Malignancies by intramuscular injection followed by intramuscular electroporation
June 29, 2011, University of Southampton Clinical Trials Unit
WT1 immunity via DNA vaccination in haematological malignancies by intramuscular injection and electroporation
A study looking at a new vaccine to treat leukaemia (WIN)
WT1 Immunity via DNA fusion Gene Vaccination in Haematological Malignancies by intramuscular injection followed by intramuscular electroporation
June 29, 2011, University of Southampton Clinical Trials Unit
.
